Postdoctoral Research Fellow - Targeted Radionuclide Therapy

Position: Preclinical Molecular Imaging

Key Information

Salary: Commencement on the salary range is subject to comparable skills and experience.

This role is eligible for ICR Sponsorship.  Support will be provided for costs associated with Visa application. If you are considering relocating to the UK, further information can be found here. 

Duration of Contract: Fixed Term for 12 months.

Hours per week: 35 hours per week (Full Time)

Closing Date: 24/07/2025

We reserve the right to close the vacancy early should we receive suitable applications for the role. 

Job Details

Under the leadership of Gabriela Kramer-Marek, we are seeking to appoint a Postdoctoral Research Fellow to join her group in order to manage studies relating to targeted radionuclide therapy (TRT) in both in vitro and in vivo models of glioblastoma.

Key Requirements

• The successful candidate must have a PhD in chemical or biomedical science (or relevant field). 
• Advanced knowledge in radiolabelling of monoclonal antibodies and small proteins 
• Expertise in development and optimisation of in vitro and in vivo efficacy assays. 
• Advanced knowledge of preclinical molecular imaging.
• Knowledge of glioblastoma biology.
• Experience in cell biology techniques(e.g. confocal microscopy, FACS analysis, Western blotting, IHC), Good verbal and written communication skills, including good presentation skills.  
• Excellent inter-personal skills with an ability to work co-operatively in a multidisciplinary setting, working closely with biologists, chemists and radiochemists.
• Possess excellent written and verbal communication skills and maintain accurate and up-to-date records of all findings

Department/Directorate Information

The Division of Radiotherapy and Imaging is investigating new imaging methods to diagnose cancer, and ways in which advances in technology and molecular biology can improve radiation treatment. It is also increasingly concerned with the use of imaging to evaluate the response to treatment in vivo, through techniques measuring aspects of tumour biology.

Preclinical Molecular Imaging Group focuses on development of innovative preclinical imaging biomarkers for non-invasive and real-time mapping of specific proteins involved either in early tumour cell response or de novo resistance to new treatment combinations, with an emphasis on targeted cancer therapies and immunotherapies. 

We encourage all applicants to access the job pack attached for more detailed information regarding this role. 

About The Institute of Cancer Research

Why work for us?

As a member of staff, you'll have exclusive access to a range of staff benefits.

The ICR is committed to supporting overseas applicants applying for roles, please click here to find out further information.

The Institute of Cancer Research, London, is one of the world's most influential cancer research institutes, with an outstanding record of achievement dating back more than 100 years. Further information about working at the ICR can be found here.

To apply, please click on the ‘Apply’ button above.

We look forward to receiving applications from all candidates, wherever in the world they are currently based. We will select those who display the potential to become, or to support, the world leading cancer researchers of the future based on their application and performance at interview. However, we particularly welcome British applicants from black and ethnic minority backgrounds, as they are under-represented within the ICR and nationwide in STEM roles.

Type / Role:

Subject Area(s):

Location(s):